Last week the Human Genomics Strategy Group (HGSG) launched their report Building on our inheritance: genomic technology in healthcare.
BIVDA welcome this report as a comprehensive and thoughtful overview of genomic medicine but BIVDA still questions why genetic or genomic tests should be singled out as being different to any other diagnostic test. BIVDA’s Chief Executive, Doris-Ann Williams said ”there is a tendency for the public to worry about anything related to genetics and where tests are concerned the same issues apply equally to non-genetic/genomic tests; it is a question of the level of importance to health relating to the information the test provides”.

Read the rest of BIVDA's statement here;